Navigation Links
Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million
Date:4/29/2012

EBITDA for the most recent fiscal year ended July 31, 2011.  Product line revenues excluding sales to Haemonetics were approximately $210 million in the same period.  Excluding the expected one-time costs associated with this acquisition and the acquisition of Hemerus, the subject of a separate press release issued today, Haemonetics anticipates the impact of both acquisitions on adjusted earnings per share to be at least neutral in fiscal 2013 and accretive in fiscal 2014 and beyond.  This transaction is subject to certain closing conditions, regulatory approvals and labor related notifications. It is expected to close during the second quarter of fiscal 2013.  Centerview Partners LLC rendered a fairness opinion to the Haemonetics Board of Directors.

As separately announced, Haemonetics will host a webcast at 8:00 am (EDT) on Monday, April 30, 2012 to discuss and answer questions about its earnings for the fourth quarter and full fiscal year ended March 31, 2012 and guidance for fiscal year 2013, which were provided in a separate press release today.  The company will also discuss both acquisitions announced today and their impact on operations and results in more detail.  Interested parties can participate at: http://phoenix.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=4752543.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers.  Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. 
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
2. Dave Helsel Joins Haemonetics as Vice President of Global Manufacturing
3. Haemonetics Reports 8% Revenue Growth for Second Quarter of Fiscal 2012, Adjusted Earnings Per Share of $0.72 and Updates Previously Provided Full Year Earnings Guidance
4. Haemonetics Sets Date for Second Quarter Fiscal Year 2012 Earnings Release: October 31, 2011
5. Haemonetics Sets Date for Fourth Quarter Fiscal Year 2011 Earnings Release: May 2, 2011
6. Haemonetics to Present at J.P. Morgan Healthcare Conference
7. Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers
8. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
9. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
10. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
11. HealthyWomen Asks: Do You Know the Signs and Symptoms of von Willebrand Disease (VWD)?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 3SBio Inc., ("3SBio") a leading biotechnology ... focusing on researching, developing, manufacturing and marketing biopharmaceutical ... an exclusive license agreement with JenKem Technology Co., ... in Mainland China of PEG-irinotecan, a long-acting polymer-drug ... over-expressed in many solid tumors, including colorectal, ovarian, ...
(Date:9/16/2014)... OAKLAND, Calif. , Sept. 16, 2014  Chairman ... that Richard (Dick) Daniels will assume the ... Foundation Hospitals and Health Plan, Inc., effective immediately. ... developing and implementing technological advancements that advance the high-quality ... members," Tyson said. " Dick Daniels has extensive ...
(Date:9/16/2014)... Endo International plc (NASDAQ: ENDP ) (TSX: ENL) ... all of the outstanding shares of Auxilium Pharmaceuticals, Inc. (NASDAQ: ... $28.10 in a cash and stock transaction valued at $2.2 ... to Auxilium,s closing price on September 16, 2014 and a ... for the previous 30 days.  Under the terms of the ...
Breaking Medicine Technology:3SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 23SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 43SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 5Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Name Interim Chief Information Officer 2Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 2Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 3Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 4Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 5Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 6Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 7
... KineMed Inc., a,pathway-based drug discovery and development ... of an investigational agent,to regenerate nerve cells in ... cognition and mood. The agent, part of a ... a behavioral test in a,preclinical model. The findings ...
... am ET, BEDMINSTER, N.J., Oct. 11 ... top-line results from,the company,s Phase 3 study of ... 83 patients with short bowel,syndrome (SBS) received either ... dose (0.10 mg/kg/day) or placebo. The,clinical efficacy endpoint ...
Cached Medicine Technology:KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 2KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model 3Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 2Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 3Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 4Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 5Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 6Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study 7
(Date:9/17/2014)... Diabetes currently has no cure. According to an ... made several breakthroughs in search for a ... indicates that cure for diabetes is still many years ... forward-thinking entrepreneurs and health professionals who made strides in ... Kenneth Pullman is one of the individuals with genuine ...
(Date:9/17/2014)... 2014 Skin management experts™ at ... of the first in the USA to introduce a ... to minimize the appearance of vertical chest lines and ... with the first FDA-cleared ultrasound based facial procedure to ... have expanded their brand into tightening and smoothing the ...
(Date:9/17/2014)... AURORA, Colo. (PRWEB) September 17, 2014 ... American Sentinel University offers tips to health IT professionals ... , A recent study by HIMSS shows demand ... high and a candidate’s skill set is the differentiating ... is that of an IT professional that has clinical ...
(Date:9/17/2014)... 2014 Lee Berman, a seasoned veteran ... appearing on The Balancing Act® airing on Lifetime Television®. ... The segment will premiere on September 19 and re-air ... airing on Lifetime Television®' with show host Julie Moran. ... for over a decade and is the Director of ...
(Date:9/17/2014)... Kingston, NY (PRWEB) September 17, 2014 ... style of wellness to the lineup at Techmanity, a ... as “the next generation of tech events,” Techmanity will ... Voom is excited to join the ranks of Cisco, ... this first ever Silicon Valley Technology Conference. , Voom ...
Breaking Medicine News(10 mins):Health News:Discover a Safe and Effective Treatment for Diabetes with The Diabetes Protocol – Vinamy 2Health News:FACE Skincare Medical Wellness Debuts Ultherapy Décolletage Treatment 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4Health News:Lee Berman Will Appear On The Balancing Act® airing on Lifetime Television® 2Health News:Health and Wellness Startup Voom Announces Sponsorship at Techmanity 2
... over-the-counter drug might reverse genetic process that leads to ... -- Researchers may have found an easy way to ... stages, as well as a way to reverse the ... over-the-counter drug. , "It,s incredibly, incredibly exciting," said ...
... the number of older Americans who delay retirement is likely ... a trend that should help ease the financial challenges facing ... Corporation study. While government projections suggest the number of ... the coming decade, RAND researchers say a more likely scenario ...
... Be ... , ... Each year, millions of Americans wait to file their federal income tax returns until the ... fast approaching, leading sleep advice web site SleepBetter.org is offering some tips to ...
... ... released version 4.3 of Replay, the award-winning, next generation backup and disaster recovery software ... Reston, ... of Replay, the award-winning, next generation backup and disaster recovery software solution. Because ...
... a condition in which the eyes turn outward while looking ... and is less common than esotropia, where the eyes turn ... of the American Journal of Ophthalmology , researchers from ... patients with intermittent exotropia over a 20-year period and found ...
... ... Suite of International Hosting and Managed Services. , ... Mississauga, Ontario (PRWEB) April 7, 2010 ... announced that it has launched the first international, multi-infrastructure cloud computing service ...
Cached Medicine News:Health News:Simple Test May Spot Early Lung Cancer 2Health News:Simple Test May Spot Early Lung Cancer 3Health News:Delayed retirement among Americans may bolster future of Social Security and Medicare, study finds 2Health News:Delayed retirement among Americans may bolster future of Social Security and Medicare, study finds 3Health News:Last-Minute Tax Tip: Get a Good Night's Sleep 2Health News:Last-Minute Tax Tip: Get a Good Night's Sleep 3Health News:De-Duplication, Compression and No Double Backups Required: AppAssure Releases the Fastest and Most Scalable Backup & Recovery Solution for Microsoft Hyper-V 2Health News:De-Duplication, Compression and No Double Backups Required: AppAssure Releases the Fastest and Most Scalable Backup & Recovery Solution for Microsoft Hyper-V 3Health News:90 percent of children with intermittent exotropia will become nearsighted by 20 years of age 2Health News:CentriLogic Launches First Canadian-Based Distributed Cloud Computing Service 2Health News:CentriLogic Launches First Canadian-Based Distributed Cloud Computing Service 3
... These offer truly exceptional quality for this ... aberration has been dramatically improved with performance ... These objectives are also corrected for spherical ... entire 22mm field of view. The DL ...
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark...
... Designed for the scientist who wants ... the TE2000E2 is a high precision Z-focus ... This makes it possible to expand ... sources and image outputs. A five-way ...
... The IX71's modular ... provides 9 access ports ... output devices. Up to ... simultaneous access to a ...
Medicine Products: